about
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesEarly revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarctionComparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imagingMetal pollutants and cardiovascular disease: mechanisms and consequences of exposureNew heparin dosing recommendations for patients with acute coronary syndromesElevated body mass index and intermediate-term clinical outcomes after acute coronary syndromesUse of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trialsWhat price pain relief?Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AHA/SCAI Guidelines on Percutaneous Coronary InterventionDoes preventive PCI work?2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelinesLoss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarctionNew approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction.Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial.Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT]).Outcome after surgery and percutaneous intervention for cardiogenic shock and left main diseaseCardiogenic shock without flow-limiting angiographic coronary artery disease: (from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry).Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT).American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease.Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise thTrends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SEarly revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials.A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry.Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to RevDesigning and implementing INTREPID, an intensive program in translational research methodologies for new investigatorsThe Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy aloneImpact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary studyRapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarctionLong-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates.
P50
Q22241919-DDAD926F-58ED-45CC-B62B-51513B76FE3CQ24683044-7F857016-13C9-46E0-B6E1-4770CADD6D96Q26827495-1A32C88E-7F6E-42B7-B69F-54C7B0A093AEQ27023569-3FD1DAA9-1B54-4D91-B124-57D1AFCABB31Q28184399-ED3753D5-9F09-4BA3-B796-5BF44731324CQ28191899-26192B2C-D34A-408E-868A-E6618F57C839Q28218699-45530A64-5609-4FCF-B3A8-86D7F707DA90Q28219284-99AC28FD-3EB6-438B-889E-B141929B6ACCQ28222097-23589E72-1565-49B2-B291-A8FB25EEEBCDQ28265917-22321896-15F6-4D5C-B6AC-9DD0ACA48123Q28295013-39D5B6DE-6332-45CF-8419-A8B58E89B0CAQ28305368-6535DE74-7302-4FE6-AC29-C9A422D013F2Q30429019-8FB02121-91ED-4BCD-9C6E-13F25EC39D9EQ30434062-D8081C75-B4C4-40F4-8D27-18732744045DQ32084485-3F36AD97-3637-40EB-BE38-070A7558BA4CQ33642414-31128CA9-86C3-4496-B07A-61618CC1AF50Q33646291-CBE7FCC2-F71B-430C-A8D7-6BDE5E5DA930Q33675490-DAE563FD-2727-494E-AE7A-8CE6300FCC88Q33749994-3B96AD4A-F39C-4B88-849B-4AF4ABF6AC39Q33765817-0F11F89B-A572-44AF-B36E-B71A766BCFADQ33792693-235A53A3-9EE7-4461-9006-6B6CB241AD88Q33872047-8DDDA202-BE9B-439D-9A7A-273B9B567E81Q33946772-AAF751F2-83C6-4C5F-9CAE-A111A44DBAE1Q33958266-2975318C-65D2-4EF8-9A98-925D9AD43737Q33978681-787E5963-ACEB-4444-A827-6D70A7419C1BQ34154032-69F5D9AD-0606-4E60-BD90-DE62ED07AB91Q34318814-5C0229FA-B706-4A81-A574-46935B315E05Q34347047-A351F283-1DCD-4F8C-BA85-BF30688FD781Q34437397-00F28911-FA1A-4FCA-A91C-560A1FB09DF9Q34454112-F06F4BFE-27CF-408F-A698-F079E4B8258DQ34471018-88B37643-E4E2-40E3-963C-E7CF014B0E39Q34497058-ACE9D55E-F5F0-407A-A43D-E43383065262Q34549223-27EB0F79-AD15-401F-8B02-DB7B6B122138Q34659902-A462A2B0-8368-43B1-A799-9419E659E843Q34714292-16AAF095-91C7-4274-B9A6-AE12B2AA33C2Q34778284-F555F510-173A-4F2E-9A31-FF43D20BE16BQ35025805-18CA9FAA-5EDD-4D00-9AC7-86A5E8B2004BQ35163124-B7DB57A8-D4FB-4B83-8BE1-316AEE9B0AF5Q35607236-BC2D8D6E-B728-4B3A-A69E-4FBABCE4CD4DQ35771737-44384892-DF3C-494C-B920-E447172B759A
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Judith S Hochman
@ast
Judith S Hochman
@en
Judith S Hochman
@es
Judith S Hochman
@nl
Judith S Hochman
@sl
type
label
Judith S Hochman
@ast
Judith S Hochman
@en
Judith S Hochman
@es
Judith S Hochman
@nl
Judith S Hochman
@sl
prefLabel
Judith S Hochman
@ast
Judith S Hochman
@en
Judith S Hochman
@es
Judith S Hochman
@nl
Judith S Hochman
@sl
P214
P244
P5361
P106
P21
P213
0000 0001 0895 3672
P214
P244
nr92025595
P31
P496
0000-0002-5889-5981
P5361
HochmanJudithS1951-
P569
1951-01-01T00:00:00Z
P735
P7859
lccn-nr92025595